In conclusion, the results of the present study indicated that NFE2L2 overexpression correlates with poor prognosis of patients and increases the infiltration levels of B cells, CD8+ T cells, CD4+ T cells, macrophages, neutrophils, and dendritic cells in many cancers, especially in LGG. The gene discussed is NFE2L2; the disease is cancer.